Zusammenfassung
Infektionen des zentralen Nervensystems (ZNS) sind eine der häufigsten Ursachen für
neurologische Defizite bei pädiatrisch-onkologischen Patienten. Nicht immer manifestieren
sich die Symptome eindeutig und erlauben daher keine scharfe Trennung von mannigfaltigen
Differenzialdiagnosen. Die wiederholte klinisch-neurologische Untersuchung ermöglicht
die gezielte Auswahl der notwendigen laborchemischen und neuroradiologischen Maßnahmen
sowie der Erregerdiagnostik. Aufgrund der hohen Mortalität sowie Folgemorbidität bei
verzögert antiinfektiös behandelten Patienten ist eine empirische Therapie mit adäquaten
Dosen notwendig, bis diagnostische Hinweise zur spezifischen Behandlung führen. Die
vorliegende Arbeit enthält Empfehlungen der Arbeitsgruppe „Infektionen bei immunsupprimierten
Kindern” der Deutschen Gesellschaft für Pädiatrische Infektiologie (DGPI) und der
Deutschen Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) zu Diagnosik
und Therapie von ZNS-Infektionen bei immunsupprimierten Kindern.
Abstract
Infections of the central nervous system (CNS) are a common cause of neurological
abnormalities in pediatric oncology patients apart from cancer disease of the CNS.
Often symptoms do not present unequivocally, impeding a clear distinction from other
differential diagnosis. Repeated neurological examinations of the patient allow selecting
the necessary laboratory tests and imaging techniques. As delayed antiinfectious treatment
is associated with high mortality and severe sequelae of survivors, patients do need
empirical therapy using adequate doses until diagnostic results allow a more specific
treatment. This article provides the recommendations of the Infectious Diseases Working
Party of the German Society for Pediatric Infectious Diseases (DGPI) and the German
Society for Pediatric Hematology/Oncology (GPOH) for diagnosis and treatment of infections
of the CNS in immunocompromised patients.
Schlüsselwörter
zentrales Nervensystem - Infektionen - Onkologie - Kinder
Key words
central nervous system - infections - oncology - children
Literatur
- 1
Archer G L, Climo M W.
Antimicrobial susceptibility of coagulase-negative staphylococci.
Antimicrob Agents Chemother.
1994;
38
2231-2237
- 2
Ashwal S.
Neurologic evaluation of the patient with acute bacterial meningitis.
Neurol Clin.
1995;
13
549-577
- 3
Bayston R.
Epidemiology, diagnosis, treatment, and prevention of cerebrospinal fluid shunt infections.
Neurosurg Clin N Am.
2001;
12
703-708
- 4
Beal M F, O'Carroll C P, Kleinman G M. et al .
Aspergillosis of the nervous system.
Neurology.
1982;
32
473-479
- 5
Bonsu B K, Harper M B.
Fever interval before diagnosis, prior antibiotic treatment, and clinical outcome
for young children with bacterial meningitis.
Clin Infect Dis.
2001;
32
566-572
- 6
Brook I.
Anaerobic infections in children.
Microbes Infect.
2002;
4
1271-1280
- 7
Brook I.
Meningitis and shunt infection caused by anaerobic bacteria in children.
Pediatr Neurol.
2002;
26
99-105
- 8
Brookhouser P E, Auslander M C, Meskan M E.
The pattern and stability of postmeningitic hearing loss in children.
Laryngoscope.
1988;
98
940-948
- 9
Buxhofer V, Ruckser R, Kier P. et al .
Successful treatment of invasive mould infection affecting lung and brain in an adult
suffering from acute leukaemia.
Eur J Haematol.
2001;
67
128-132
- 10
Calfee D P, Wispelwey B.
Brain abscess.
Semin Neurol.
2000;
20
353-360
- 11
Camarata P J, Dunn D L, Farney A C. et al .
Continual intracavitary administration of amphotericin B as an adjunct in the treatment
of aspergillus brain abscess: case report and review of the literature.
Neurosurgery.
1992;
31
575-579
- 12
Chamberlain M C, Kormanik P A, Barba D.
Complications associated with intraventricular chemotherapy in patients with leptomeningeal
metastases.
J Neurosurg.
1997;
87
694-699
- 13
Chimelli L, Mahler-Araujo M B.
Fungal infections.
Brain Pathol.
1997;
7
613-627
- 14
Clemons K V, Sobel R A, Williams P L. et al .
Comparative toxicities and pharmacokinetics of intrathecal lipid (amphotericin B colloidal
dispersion) and conventional deoxycholate formulations of amphotericin B in rabbits.
Antimicrob Agents Chemother.
2001;
45
612-615
- 15
de Montalembert M.
[Bacterial meningitis in children: how many lumbar punctures?].
Pediatrie.
1993;
48
17-19
- 16
Denning D W, Stevens D A.
Antifungal and surgical treatment of invasive aspergillosis: review of 2 121 published
cases.
Rev Infect Dis.
1990;
12
1147-1201
- 17
Dooley D P, Carpenter J L, Rademacher S.
Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the
literature.
Clin Infect Dis.
1997;
25
872-887
- 18
Duke T, Mokela D, Frank D. et al .
Management of meningitis in children with oral fluid restriction or intravenous fluid
at maintenance volumes: a randomised trial.
Ann Trop Paediatr.
2002;
22
145-157
- 19
Einsele H, Bertz H, Beyer J. et al .
Infectious complications after allogeneic stem cell transplantation: epidemiology
and interventional therapy strategies - guidelines of the Infectious Diseases Working
Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Ann Hematol.
2003;
82
S 175-S 185
- 20
Elgamal E A, Murshid W R.
Intracavitary administration of amphotericin B in the treatment of cerebral aspergillosis
in a non immune-compromised patient: case report and review of the literature.
Br J Neurosurg.
2000;
14
137-141
- 21
Farr B M, Scheld W M.
Nosocomial meningitis.
Serious Hospital Inf.
1998;
10
1-7
- 22
Fernandez-Viladrich P, Corbella X, Corral L. et al .
Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii
with intraventricular colistin sulfomethate sodium.
Clin Infect Dis.
1999;
28
916-917
- 23
Guppy K H, Thomas C, Thomas K. et al .
Cerebral fungal infections in the immunocompromised host: a literature review and
a new pathogen - Chaetomium atrobrunneum: case report.
Neurosurgery.
1998;
43
1463-1469
- 24
Hall W A, Martinez A J, Dummer J S. et al .
Nocardial brain abscess: diagnostic and therapeutic use of stereotactic aspiration.
Surg Neurol.
1987;
28
114-118
- 25
Hedlund G L, Boyer R S.
Neuroimaging of postnatal pediatric central nervous system infections.
Semin Pediatr Neurol.
1999;
6
299-317
- 26
Kanchanapoom T, Koirala J, Goodrich J. et al .
Treatment of central nervous system infection by vancomycin-resistant enterococcus
faecium.
Diagn Microbiol Infect Dis.
2003;
45
213-215
- 27
Kaplan K.
Brain abscess.
Med Clin North Am.
1985;
69
345-360
- 28
Kaplan S L.
Clinical presentations, diagnosis, and prognostic factors of bacterial meningitis.
Infect Dis Clin North Am.
1999;
13
579-594
- 29
Klibanov O M, Filicko J E, DeSimone J A. et al .
Sensorineural hearing loss associated with intrathecal vancomycin.
Ann Pharmacother.
2003;
37
61-65
- 30
Krupova Y, Sejnova D, Dzatkova J. et al .
Prospective study on fungemia in children with cancer: analysis of 35 cases and comparison
with 130 fungemias in adults.
Support Care Cancer.
2000;
8
427-430
- 31
LePage E.
Using a ventricular reservoir to instill amphotericin B.
J Neurosci Nurs.
1993;
25
212-217
- 32
Link H, Bohme A, Cornely O A. et al .
Antimicrobial therapy of unexplained fever in neutropenic patients - guidelines of
the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology
and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft
Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German
Cancer Society).
Ann Hematol.
2003;
82
S 105-S 117
- 33
Lipton J D, Schafermeyer R W.
Evolving concepts in pediatric bacterial meningitis - Part I: Pathophysiology and
diagnosis.
Ann Emerg Med.
1993;
22
1602-1615
- 34
Lukes S A, Posner J B, Nielsen S. et al .
Bacterial infections of the CNS in neutropenic patients.
Neurology.
1984;
34
269-275
- 35
Lutsar I, McCracken G H, Friedland I R.
Antibiotic pharmacodynamics in cerebrospinal fluid.
Clin Infect Dis.
1998;
27
1117-1127
- 36
Marchiori C, Tonon E, Boscolo Rizzo P. et al .
[Brain abscesses after extracranial infections of the head and neck area].
Hno.
2003;
51
813-822
- 37
Maschmeyer G.
Interventional antimicrobial therapy in febrile neutropenic patients.
Diagn Microbiol Infect Dis.
1999;
34
205-212
- 38
Mathisen G E, Johnson J P.
Brain abscess.
Clin Infect Dis.
1997;
25
763-779
- 39
Matsubara H, Makimoto A, Higa T. et al .
Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus
aureus with intrathecal vancomycin in an allogeneic peripheral blood stem cell transplant
recipient.
Bone Marrow Transplant.
2003;
31
65-67
- 40
Mayhall C G, Archer N H, Lamb V A. et al .
Ventriculostomy-related infections. A prospective epidemiologic study.
N Engl J Med.
1984;
310
553-559
- 41
Mechleb B, Khater F, Eid A. et al .
Late onset Ommaya reservoir infection due to Staphylococcus aureus: case report and
review of Ommaya Infections.
J Infect.
2003;
46
196-198
- 42 Mikrobiologie DGfHu .Infektionen des Zentralnervensystems. Qualitätsstandards in
der mikrobiologisch-infektiologischen Diagnostik. Urban und Fischer, München 2001
- 43
Moller K, Larsen F S, Bie P. et al .
The syndrome of inappropriate secretion of antidiuretic hormone and fluid restriction
in meningitis - how strong is the evidence?.
Scand J Infect Dis.
2001;
33
13-26
- 44
Nau R, Bruck W.
Neuronal injury in bacterial meningitis: mechanisms and implications for therapy.
Trends Neurosci.
2002;
25
38-45
- 45
Nau R, Sorgel F, Prange H W.
Pharmacokinetic optimisation of the treatment of bacterial central nervous system
infections.
Clin Pharmacokinet.
1998;
35
223-246
- 46
Nenoff P, Kellermann S, Schober R. et al .
Rhinocerebral zygomycosis following bone marrow transplantation in chronic myelogenous
leukaemia. Report of a case and review of the literature.
Mycoses.
1998;
41
365-372
- 47 Neurologie DGf .Leitlinien für Diagnostik und Therapie in der Neurologie. 2. Überarbeitung
2003
- 48 Neuropädiatrie Gf. Deutsche Gesellschaft für Kinderheilkunde und Jugendmedizin
.Leitlinien Kinderheilkunde und Jugendmedizin. Urban und Fischer, München 2001
- 49
Paris M M, Hickey S M, Uscher M I. et al .
Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant
pneumococcal meningitis.
Antimicrob Agents Chemother.
1994;
38
1320-1324
- 50
Pfausler B, Spiss H, Beer R. et al .
Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid
drains: a prospective randomized trial of intravenous compared with intraventricular
vancomycin therapy.
J Neurosurg.
2003;
98
1040-1044
- 51
Pfisterer W, Muhlbauer M, Czech T. et al .
Early diagnosis of external ventricular drainage infection: results of a prospective
study.
J Neurol Neurosurg Psychiatry.
2003;
74
929-932
- 52
Pomeroy S L, Holmes S J, Dodge P R. et al .
Seizures and other neurologic sequelae of bacterial meningitis in children.
N Engl J Med.
1990;
323
1651-1657
- 53
Pruitt A A.
Nervous system infections in patients with cancer.
Neurol Clin.
2003;
21
193-219
- 54
Saez-Llorens X.
Brain abscess in children.
Semin Pediatr Infect Dis.
2003;
14
108-114
- 55
Saez-Llorens X, McCracken G H.
Bacterial meningitis in children.
Lancet.
2003;
361
2139-2148
- 56 Scholz H, Behloradsky B H, Heininger U. et al .DGPI Handbuch Infektionen bei Kindern
und Jugendlichen. 4. Aufl. Futuramed-Verlag, München 2004
- 57
Schroten H.
Diagnostik und Therapie der bakteriellen Meningitis.
Monatsschrift Kinderheilkd.
2004;
152
382-390
- 58
Segal-Maurer S, Mariano N, Qavi A. et al .
Successful treatment of ceftazidime-resistant Klebsiella pneumoniae ventriculitis
with intravenous meropenem and intraventricular polymyxin B: case report and review.
Clin Infect Dis.
1999;
28
1134-1138
- 59
Sell S H.
Long term sequelae of bacterial meningitis in children.
Pediatr Infect Dis.
1983;
2
90-93
- 60 Shah S, Ohlsson A, Shah V. Intraventricular antibiotics for bacterial meningitis
in neonates. Cochrane Database Syst Rev 2004; CD004496
- 61
Snedeker J D, Kaplan S L, Dodge P R. et al .
Subdural effusion and its relationship with neurologic sequelae of bacterial meningitis
in infancy: a prospective study.
Pediatrics.
1990;
86
163-170
- 62
Sommers L M, Hawkins D S.
Meningitis in pediatric cancer patients: a review of forty cases from a single institution.
Pediatr Infect Dis J.
1999;
18
902-907
- 63
Stapleton S R, Bell B A, Uttley D.
Stereotactic aspiration of brain abscesses: is this the treatment of choice?.
Acta Neurochir (Wien).
1993;
121
15-19
- 64 Steiger H J, Reuelen H J. Manual Neurochirurgie. Ecomed, Landsberg 1999
- 65
Syrogiannopoulos G A, Lourida A N, Theodoridou M C. et al .
Dexamethasone therapy for bacterial meningitis in children: 2- versus 4-day regimen.
J Infect Dis.
1994;
169
853-858
- 66
Talan D A, Zibulewsky J.
Relationship of clinical presentation to time to antibiotics for the emergency department
management of suspected bacterial meningitis.
Ann Emerg Med.
1993;
22
1733-1738
- 67
Tan T Y, Pitman I, Penrose-Stevens A. et al .
Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection
with quinupristin/dalfopristin and review of the literature.
J Infect.
2000;
41
95-97
- 68
Tunkel A R, Scheld W M.
Acute bacterial meningitis.
Lancet.
1995;
346
1675-1680
- 69 de Beek D van, de Gans J, McIntyre P. et al .Corticosteroids in acute bacterial
meningitis. Cochrane Database Syst Rev 2003; CD004305
- 70
den Berg H van, Gerritsen E J, Haraldsson A. et al .
Changes in cell and protein content of cerebrospinal fluid in children with acute
lymphoblastic leukaemia after allogeneic bone marrow transplantation.
Bone Marrow Transplant.
1993;
12
615-619
- 71
Wald E R, Kaplan S L, Mason E O. et al .
Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group.
Pediatrics.
1995;
95
21-28
- 72
Williamson J C, Glazier S S, Peacock J E.
Successful treatment of ventriculostomy-related meningitis caused by vancomycin-resistant
Enterococcus with intravenous and intraventricular quinupristin/dalfopristin.
Clin Neurol Neurosurg.
2002;
104
54-56
- 73
Yaramis A, Gurkan F, Elevli M. et al .
Central nervous system tuberculosis in children: a review of 214 cases.
Pediatrics.
1998;
102
E 49
- 74
Yogev R.
Cerebrospinal fluid shunt infections: a personal view.
Pediatr Infect Dis.
1985;
4
113-118
Dr. Pablo Hernáiz Driever
Klinik für Pädiatrie mit Schwerpunkt Onkologie und Hämatologie · Charité-Universitätsmedizin
Berlin
Augustenburger Platz 1
D-13353 Berlin
Phone: 0 30/4 50 66 61 73
Fax: 0 30/4 50 56 69 06
Email: pablo.hernaiz@charite.de